Hypofractionated chemoradiation for head and cancer: Data from the PET NECK trial

There has been increased interest in hypofractionated accelerated chemoradiation for head and neck cancer during the recent first peak of the COVID-19 pandemic. Prospective data regarding this approach from randomised trials is lacking. In the PET NECK study, 564 patients with squamous cell carcinom...

Descripción completa

Detalles Bibliográficos
Autores principales: Vreugdenhil, M., Fong, Charles, Sanghera, Paul, Hartley, Andrew, Dunn, Janet, Mehanna, Hisham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733600/
https://www.ncbi.nlm.nih.gov/pubmed/33321287
http://dx.doi.org/10.1016/j.oraloncology.2020.105112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733600/
https://www.ncbi.nlm.nih.gov/pubmed/33321287
http://dx.doi.org/10.1016/j.oraloncology.2020.105112

Ejemplares similares